Food and Drug Administration to treat obese adults in June 2021 but has yet to get a nod in Korea
Adv Drug Del Rev 55:12611277 Calvillo-Rodrguez KM, Mendoza-Reveles R, Gmez-Morales L, Uscanga-Palomeque AC, Karoyan P, Martnez-Torres AC, Rodrguez-Padilla C (2022) PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells
The limited available data to date do not suggest an adverse safety signal in patients with breast cancer
Antithyroid drugs, while effective in controlling thyroid hormone production, can lead to adverse side effects such as liver damage and a decrease in white blood cells, making patients susceptible to infections
Cost is a genuine consideration
The sections were then counterstained with hematoxylin